ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Algernon to drop Phase III trial of Ifenprodil for Covid-19
July 07, 2021Algernon Pharmaceuticals has plans not to progress the development of its drug candidate, Ifenprodil, into a Phase III clinical trial for Covid-19. -
Algernon’s Ifenprodil lowers interleukin 6 in Phase IIb/III Covid-19 trial
May 13, 2021Algernon Pharmaceuticals has reported that NP-120 (Ifenprodil) statistical significantly lowered interleukin 6 (IL-6) in its Phase IIb/III trial to treat Covid-19. -
Algernon submits IND application with FDA for possible Covid-19 treatment
May 27, 2020Algernon Pharmaceuticals has completed the submission of an investigational new drug (IND) application to the US Food and Drug Administration (FDA) to assess the Ifenprodil in the phase 2b/3 clinical study to treat Covid-19 patients.
Pharma Sources Insight January 2025
